Clinical Trial Update: Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating infusions of umbilical cord–derived mesenchymal stem cells and mononuclear cells in people with Type 1 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mononuclear Cells Infusion
• Umbilical Mesenchymal Stem Cells

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: UNKNOWN